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The beta amyloid (APP) cleaving enzyme (BACE1) has been a drug target for Alzheimer’s
Disease (AD) since 1999 with lead inhibitors now entering clinical trials. In 2011, the
paralog, BACE2, became a new target for type II diabetes (T2DM) having been identified
as a TMEM27 secretase regulating pancreatic β cell function. However, the normal
roles of both enzymes are unclear. This study outlines their evolutionary history and
new opportunities for functional genomics. We identified 30 homologs (UrBACEs) in
basal phyla including Placozoans, Cnidarians, Choanoflagellates, Porifera, Echinoderms,
Annelids, Mollusks and Ascidians (but not Ecdysozoans). UrBACEs are predominantly
single copy, show 35–45% protein sequence identity with mammalian BACE1, are ∼100
residues longer than cathepsin paralogs with an aspartyl protease domain flanked by
a signal peptide and a C-terminal transmembrane domain. While multiple paralogs in
Trichoplax and Monosiga pre-date the nervous system, duplication of the UrBACE in fish
gave rise to BACE1 and BACE2 in the vertebrate lineage. The latter evolved more rapidly as
the former maintained the emergent neuronal role. In mammals, Ka/Ks for BACE2 is higher
than BACE1 but low ratios for both suggest purifying selection. The 5’ exons show higher
Ka/Ks than the catalytic section. Model organism genomes show the absence of certain
BACE human substrates when the UrBACE is present. Experiments could thus reveal
undiscovered substrates and roles. The human protease double-target status means that
evolutionary trajectories and functional shifts associated with different substrates will
have implications for the development of clinical candidates for both AD and T2DM. A
rational basis for inhibition specificity ratios and assessing target-related side effects will
be facilitated by a more complete picture of BACE1 and BACE2 functions informed by their
evolutionary context.
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INTRODUCTION
The amino acid aggregates of Aβ peptides forming the major
component of plaques characteristic of Alzheimer’s Disease (AD)
result from N-terminal cleavage of the amyloid precursor protein
(APP) (Goedert and Spillantini, 2006) mediated by an aspartyl
protease referred to as Beta-site APP Cleaving Enzyme 1 (BACE1)
(Hussain et al., 1999; Sinha et al., 1999; Vassar et al., 1999; Yan
et al., 1999). BACE1 cleaves APP between residues 671 and 672
leading to extracellular release of beta-cleaved soluble APP. The
cell-associated carboxy-terminal fragment of APP is subsequently
released by the gamma-secretase complex of proteins facilitat-
ing intra-membrane proteolysis by the presenilin proteins, PSEN1
and PSEN2 (Selkoe andWolfe, 2007). Because neurotoxic Aβ pep-
tide production needs the combination of BACE1 and gamma
secretase, both have been intensively pursued as AD drug tar-
gets for well over a decade (Durham and Shepherd, 2006; Olson
and Albright, 2008; Karran et al., 2011). For gamma secretase
inhibitors, recent clinical trial results have been disappointing,
although second-generation, Notch-sparing compounds may still
hold promise (Xia et al., 2012).
Pursued by many of the same companies in parallel to gamma
secretase, global efforts toward BACE1 inhibition have been
intense (Probst and Xu, 2012), culminating in the progression
of several optimized leads toward their clinical phases (Stamford
et al., 2012; Weiss et al., 2012; Hilpert et al., 2013). The prospects
for success compared to gamma secretase seem more hopeful
for three reasons. Firstly, the mouse BACE1 knock-out remains
the only one of nearly 2000 tested viable gene ablations that
robustly alter brain Aβ levels (Toyn et al., 2010). Secondly,
LY2811376 (PubChem CID 44251605) has provided a proof-of-
concept Aβ reduction in human clinical studies, despite progres-
sion being halted because of probable compound-specific (rather
than target-specific) retinal toxicology (May et al., 2011). Thirdly,
there has been new, indirect genetic target validation in the form
of an A673T mutation in APP that was AD-protective due to
reduced BACE1 cleavage (Jonsson et al., 2012).
Within a year of the discovery of BACE1 its paralog BACE2
(Q9Y5Z0) was also published by multiple groups (Acquati et al.,
2000; Farzan et al., 2000; Hussain et al., 2000). This has 50% iden-
tity to BACE1 over 518 residues in humans. The next-highest
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alignment score against human proteins is cathepsin E (CATE,
P14091) with 27% identity over 396 residues. A phylogenetic
analysis has established that the BACEs are parologous to pepsins
and cathepsins, although they may have shared origins with
homologs found in the marine proteobacterian genus Shewanella
(Rawlings and Bateman, 2009). The bi-lobed tertiary structure of
the A1 proteases suggests this family has arisen from a duplication
and fusion event. Even though the two symmetrical lobes of the
PDB structures have recognizably similar folds, the residual inter-
nal sequence similarity from the ancient duplication is restricted
to the short motif around each active site Asp.
Since investigations on the normal roles of BACE1 and BACE2
are too extensive to review here (particularly for BACE1) we
present just a selection of citations to give an overview (Table 1).
The current picture of BACE function is increasingly complex
but trends can be discerned. The first trend is that the continued
confirmation of new in vivo substrates points toward pleiotropic
roles. The second is that, while the picture of neuronal substrate
processing for BACE1 and pancreatic substrates for BACE2 holds
true, there is increasing evidence of overlap. In particular, BACE1
functions may extend to non-CNS tissues and cell types in which
the same and/or different substrates can be processed. The third
trend is the emergence of role differences between humans, mice
and fish.
A notable 2011 report unexpectedly promoted BACE2 to an
equivalent drug target status to that which BACE1 had imme-
diately acquired in 1999. Since TMM27 (Q9HBJ8) was shown
to be a regulator of normal beta cell function the research team
went on to show that insulin-resistant mice treated with a BACE2
inhibitor (CID 50938551) displayed both augmented β cell mass
and improved control of glucose homeostasis due to increased
insulin levels (Esterhazy et al., 2011). These findings therefore
constituted an initial drug target validation of BACE2 inhibition
for type II diabetes (T2DM). While the molecular mechanisms
by which BACE2 deficiency or inhibition affect β cell function
and proliferation are unknown, they may involve not only the sta-
bilization of TMEM27 but additional BACE2 substrates (Stützer
et al., 2013).
The double drug target status of the BACEs, together with
the still-incomplete functional pictures of both enzymes, presents
an opportunity for a phylogenomic investigation. This is facil-
itated by the increasing breadth (i.e., more species) and depth
(i.e., more phyla) of completed genomes, draft assemblies and
transcript data. For BACE1, the existence of sequence similarity
matches in Ciona intestinalis and Strongylocentrotus purpuratus
had already been noted (Stockley and O’Neill, 2008; Venugopal
et al., 2008). Here we focus on the discovery of novel homologs
from basal phyla. From finding a predominantly single-copy
UrBACE in most eumetazoans we identify a major duplication
event approximately corresponding to the origin of the jawed
vertebrates (Gnathostomata).We also suggest that frequent dupli-
cation and loss events may have contributed to the evolution of
this gene family.
METHODS
REFERENCE SEQUENCES AND TERMINOLOGY
Detailed information on the search sequences can be found in the
appropriate UniprotKB/Swiss-Prot records for BACE1_HUMAN
Table 1 | Summaries of findings related to normal functions of BACE1
(Upper section) and BACE2 (lower section) in chronological order
(KO = gene knock-out).
Observation References
BACE1
KO-mice showed subtle neurochemical deficits and
behavioral changes
Dominguez et al.,
2005
Cleaved APP ectodomain involvement in normal
nerve cells and Aβ peptides dampening neuronal
hyperactivity
Ma et al., 2007
Sixty-eight epithelial cell line substrates detected,
many membrane-anchored and involved in
contact-dependent intercellular communication
Hemming et al.,
2009
Voltage-gated sodium channel subunits (SCN4B,
O60939 and related subunits) substrates for
regulation of Nav1 channel metabolism
Kovacs et al., 2010
Neuregulin, NRG1, Q022979, substrate for control
of nerve cell myelination
Fleck et al., 2012
Amyloid-like protein 2 (APP2, Q06481) substrate
for ectodomain fragments
Hogl et al., 2011
Brain substrates in inhibitor-treated and KO mice
involved in neurites and synapses
Kuhn et al., 2012
Thirteen non-amyloidogenic substrates reviewed Dislich and
Lichtenthaler, 2012
Pancreatic ectodomain shedding regulates broad
set of β-cell-enriched substrates
Stützer et al., 2013
Zebrafish KO indicates substrates related to
neurite outgrowth and axon guidance, including
plexin A3, B0S5N4, and glypican-1 (F1QCC6)
Hogl et al., 2013
Zebrafish KO shows peripheral hypomyelination Van Bebber et al.,
2013
BACE2
Processes APP at the beta-secretase site Hussain et al., 2000
Tissue distribution implies functions distinct from
neuronal BACE1
Sun et al., 2005
KO mice normal but neonatal mortality increase in
BACE1/2 double-KO
Dominguez et al.,
2005
Processes APP but reduces Aβ production Sun et al., 2006
Secretase of the plasma membrane protein
TMM27 (Q9HBJ8) in mice and in human β cells
Esterhazy et al.,
2011
Pancreatic ectodomain shedding regulates narrow
set of β-cell-enriched substrates, including SEZ6L
(Q9BYH1) and SEZ6L2 (Q6UXD5)
Stützer et al., 2013
Role in processing mouse pigment cell-specific
Melanocyte Protein, PMEL, Q60696
Rochin et al., 2013
Zebrafish KO melanocyte migration phenotype.
Double KO (Bace1−/−; Bace2−/−) viable and does
not enhance the single mutant phenotypes,
indicating non-redundant functions in fish
Van Bebber et al.,
2013
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(P56817) and BACE2_HUMAN (Q9Y5Z0). Additional infor-
mation is available in the MEROPS peptidase database via the
identifiers A01.004 (http://merops.sanger.ac.uk/cgi-bin/pepsum?
mid=a01.004) and A01.041 (http://merops.sanger.ac.uk/cgi-bin/
pepsum?mid=A01.041), respectively (Rawlings et al., 2008).
Comparative genomic data can be accessed via the Ensembl
entry points for ENSG00000186318 (http://www.ensembl.org/
Homo_sapiens/Gene/Summary?g=ENSG00000186318;r=11:117
156402-117186975) and ENSG00000182240 for BACE1 and
BACE2, respectively (http://www.ensembl.org/Homo_sapiens/
Gene/Summary?db=core;g=ENSG00000182240;r=21:42539728-
42648524). In summary BACE1 is transcribed from 9 exons
on human chromosome 11q23.3 and BACE2 from 9 exons on
21q22.3.
To reduce repetition we use the following terminology. While
BACE is technically a BACE1 synonym (whose usage preceded the
latter) we use the term BACE(s) to refer to the pan-vertebrate
parologous pairs of BACE1 and BACE2. The term BACE-like is
reserved for high-scoring similarity matches that we detected but
that were not unequivocally assignable to either. Where our anal-
ysis has clearly resolved these to single (or low multiple) ORFs in
basal phyla we use the term UrBACE (see Results).
SEQUENCE SEARCHING AND CHECKING
The utility of selected resources for the phylogenetic investi-
gation of proteases and their substrates has been previously
noted (Southan, 2007). We made use of Ensembl GeneTree as
an automated starting point from which we manually checked
selected ORFs and proceeded to search for new homologs in
the sequence databases (Ruan et al., 2008). For gene predic-
tions or transcript translations we inspected NCBI BLASTP
output for similarity matches, truncations, insertions or dele-
tions, using default search parameters. All BACE-like, genomic
pipeline-predicted ORFs were checked by BLASTX searches
against transcript collections. In a few cases GENESCAN runs
on genomic DNA for de novo protein prediction extended
the ORFs.
InterProScan was used to detect extended familymatches, local
domain matches, N-terminal patterns indicative of signal pep-
tides, C-terminal transmembrane domains and to detect breaks
in the global alignment profiles. Initially we were confounded by
cases where direct THMM transmembrane and SignalP predic-
tion indicated terminal TMs apparently missed by InterProScan.
We eventually discovered that a cryptic licensing restriction in
the online version of InterProScan meant sequences had to be
changed by a single residue from identical UniProt entries before
TMs were generated.
By performing TBLASTN searches of ORFs against both
Expressed Sequence Tags (dbEST) and the Transcriptome
Shotgun Assembly sequence division (TSA) we found many
new BACE-like sequences. These included complete and partial
cDNAs from basal phyla that do not yet have complete genome
coverage. Such searches were also used to extend truncated
genomic-predicted ORFs. The expanding coverage of mammals
and major vertebrate phyla by Ensembl has produced dense cov-
erage for BACEs via the automated population of GeneTree. We
therefore focused our collation efforts on expanding the more
sparsely populated deep phylogeny which is currently restricted
to just Ciona in Ensembl.
We selected a limited number of close, cathepsin-like paralogs
to these BACE-like sequences as out-group sequences to resolve
the possible evolutionary patterns. These combined approaches
allowed us to generate a large set of sequences most of which were
novel. We also used representative human substrates of BACE1
and BACE2 to search against sets of predicted proteins from
model organism genomes to identify their phylogenetic distribu-
tions. We included presenilin 1 (PSEN1), which is also associated
with secretase action, via APP being a substrate. Since this is
highly conserved with a deep phylogenetic pattern it served as a
useful similarity score calibration.
ALIGNMENT AND PHYLOGENETIC ANALYSIS
The initial stages used COBALT for checking as the
sequences were being iteratively assembled and cross-checked
(Papadopoulos and Agarwala, 2007). The final alignments were
made using PRANK (Löytynoja and Goldman, 2010). Following
recommendations of a recent evaluation (Gonnet, 2012), phy-
logenetic analysis was carried out by applying BioNJ (Gascuel,
1997) (http://www.phylogeny.fr/version2cgi/onetask.cgi?task
type=bionj) to PRANK protein alignments. Tree reconstructions
were carried out using default parameters.
SEQUENCE BLOCKS AND GAPPED ALIGNMENTS
As an adjunct to phylogenetic relationships, multiple alignments
can also be used to extract conserved sequence blocks. These
were generated with Blockmaker and then analyzed by WebLogo
to provide a comparative visual description of residue conser-
vation at each position (Henikoff et al., 1995; Crooks et al.,
2004). It should be noted that this approach is selective, com-
pared to tree construction, in that gapped or very divergent
sequences are excluded. Block sequence sections and individ-
ual residues from the logos were then mapped to a BACE1
2D transformation available in PDBSum (Laskowski, 2009). The
important C-terminal domains of BACE-like sequences proved
difficult to discern in global multiple alignments or block-type
approaches. We addressed this by using the T-Coffee algo-
rithm because this is optimized for gapping (Rausch et al.,
2008).
Ka/Ks ANALYSIS
Ka/Ks ratios were estimated on subsets of well-founded cDNAs of
BACE1 and BACE2 separately. The cDNA sequences were derived
only from mammals to minimise effects of multiple mutations
(although these cannot be eliminated completely) and included
only coding sequence. Ka/Ks calculations were carried out using
SLAC (Kosakovsky Pond and Frost, 2005) for complete coding
regions and for sub-regions corresponding to functional domains
and to individual exons. Boundaries of functional domains and
intron/exon boundaries were taken from the CCDS database
(Pruitt et al., 2009)
DATA AVAILABILITY, RE-USE, UPDATING, AND CONNECTIVITY
We have taken four complementary approaches to data sharing
that we hope will ensure persistence, re-use, updating, and
facilitate connectivity (Leebens-Mack et al., 2006; Stoltzfus et al.,
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2012; Drew, 2013). Firstly, we have used the supplementary data
option provided by this journal, with the specific data being
referred to in results. Secondly, we have made a deposition in
TreeBase (Anwar and Hunt, 2009) of a Nexus file representing the
alignment used for the phylogeny analysis. The permanent URL
for this Nexus file is http://purl.org/phylo/treebase/phylows/
study/TB2:S14732. As a third measure we have deposited the sup-
plementary data on figshare as an open archive (Singh, 2011), at
http://figshare.com/articles/Supplementary_Data_for_Southan_
Hancock_BACE_evolution_paper/855620.
It is important to note that the majority of the sequences we
have collated are not yet available as stable protein accession num-
bers for full-length ORFs and their primary nucleotide records
are spread across many database divisions. In addition, the rate
of generation and revision (e.g., new cDNA and genome assem-
bly updates) is such that our TreeBase deposition will become
outdated. We have thus included (both in the supplementary
data and the figshare link) a complete FASTA compilation of the
sequences. These can either be used as-is for different alignment
approaches or updated via new database searches.
Fourthly, we have submitted a representative complete cDNA
and protein sequence of the Ciona intestinalis UrBACE to
the Third Party Annotation (TPA) division of the European
Nucleotide Archive (ENA). This was assembled using EST data
to consolidate the gene prediction. This will have the accession
number HE967761. We will ensure this is updated to link to
the eventual PubMed ID, giving researchers the possibility of
connecting to our work directly via a sequence search.
RESULTS
CLASSIFYING BACE-LIKE ORFs
The exercise of finding and checking new BACE-like proteins
presented the following technical challenges:
• Discerning what data types for which organism were in which
source and/or database division (e.g., cDNA data could be in
mRNA(nr), dbEST, TSA, or all three).
• Ascertaining completion status at the genome assembly level
and coverage at the transcript level (e.g., we could not easily
resolve the Monosiga ovata EST-derived ORFs against the JGI
Monosiga brevicolis genome-derived ORFs).
• Encountering the same or different ORFs from the same organ-
ism in multiple pipelines (e.g., JGI, BCM, UCSC, XP, Ensembl,
RefSeq, and TrEMBL). It was often unclear which organisms
were unique to which portals or which database records were
transitively circular (i.e., cross-referenced back to the same
primary sequence data) or derived via independent pipeline
results.
• For both genomic prediction and cDNA data we commonly
encountered the error types of terminal truncations, internal
exon losses and chimeras.
Fortunately multiple alignments are tolerant of at least moder-
ate gaps or truncations and can still be informative with respect
to tree topology and branch lengths reflecting protein sequence
similarity scores. Consequently, some partial sequences were used
to populate otherwise sparse sections of the tree.
We classified sequences as BACE-like by two approaches. The
first was identifying them as probable orthologs extending across
major phyla. The second was discriminating them from cathep-
sins (i.e., as not cathepsin-like). Our triage utilized the following
criteria:
1. Reciprocal BLAST similarity (i.e., using the query best match
as a new database query). This always grouped BACEs at the
top of the hit list.
2. Matches of ∼35% identity or more, extending across the
major part of the ORF without over-gapping (e.g., the
Planarium sequence, with one of the lowest similarity scores
in the set, matches human BACE1 with an E-value of 3e–58
representing 34% identity over 387 residues with 7% gaps).
3. The similarity scores to cathepsin homologs in any sin-
gle species were distinctly lower (e.g., dropping to ∼25%
identity over ∼350 residues with ∼20% gapping).
4. Sequences were typically ∼100 residues longer than cathep-
sin homologs.
5. A unique pattern of a predicted N-terminal signal peptide
and a C-terminal transmembrane (CTM) either side of the
protease domain was present. The CTM was absent from all
analyzed cathepsin homologs while they typically also had
N-terminal signal peptides.
6. Extended global alignment matches, together with individ-
ual diagnostic sections including at least one of the profiles
for BACE (this was nearly always to BACE1 not BACE2).
7. Cathepsin homologs and vertebrate BACE2 sequences con-
sistently showed two matches to the Prosite PS00141 regular
expression diagnostic for the aspartyl active site. In contrast,
all BACE1 and BACE-like sequences showed only the single
proximal N-terminal match.
8. The gene structure of all BACE-like sequences, judged as
complete ORFs, consisted of at least 9 exons. Most cathepsin
homologs also showed this but some were single-exon.
9. The construction of provisional phylogenetic gene trees and
testing different parameterizations, including cathepsins as
out-groups, was used to support grouping into BACE-like
or BACE sub-families.
Using the methods described we assembled the sequences speci-
fied in Table 2.
NEGATIVE AND BORDERLINE RESULTS
With the caveat of data incompleteness in organisms represented
only by draft genomes, BACE-like proteins were not detected
(i.e., the BACE1 search probe matched only cathepsins at ∼25%
identity) in the folowing: Saccharomyces cerevisiae,Caenorhabditis
elegans, Drosophila melanogaster, Daphnia pulex, Arabidopsis
thaliana, Amphimedon queenslandica, Dictyostelium discoideum,
Plasmodium falciparum, and Strigamia maritima. In addition, by
using the taxonomic filters on the UniProt BLAST options, the
entire protein collections from bacteria, plants, fungi, archaea and
nematodes were also found to be negative. In the light of these
results we dispute the published claim of the discovery of a BACE-
like sequence in Drosophila melanogaster and the consequent
annotation as such in the protein databases (Carmine-Simmen
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Table 2 | BACEs, BACE-like sequences and homologs used for phylogenetic analysis.
Short sequence name Species name Common name NCBI Tax ID UniProt ID Protein length
Ur-BACE
Mono_ovat_A Monosiga ovata Choanoflagellate 81526 459
Mono_ovat_B Monosiga ovata Choanoflagellate 81526 541
Tric_adhe_A Trichoplax adhaerens Tricoplax 10228 545
Tric_adhe_B Trichoplax adhaerens Tricoplax 10228 B3RU95 505
Tric_adhe_C Trichoplax adhaerens Tricoplax 10228 B3RU94 428
Nema_vect Nematostella vectensis Sea Anemone 45351 479
Aipt_pall Aiptasia pallida Sea Anemone 12566 488
Hydr_mag Hydra magnipapillata Hydra 6085 412
Clyti_hem Clytia hemisphaerica Sponge 252671 474
Acro_mill Acropora millepora Stony Coral 45264 365
Clon_sine Clonorchis sinensis Oriental Liver Fluke 79923 506
Schi_japo Schistosoma japonicum Fluke 6182 488
Schi_mans Schistosoma mansoni Fluke 6183 G4VD03 507
Plan_schm Schmidtea mediterranea Planarium 79327 516
Capi_tela Capitella telata Polychaete annelid 283909 504
Mere_mere Meretrix meretrix Asiatic Hard Clam 291251 362
Rudi_phil Ruditapes philippinarum Manila Clam 129788 186
Vill_lien Villosa lienosa Freshwater Mussel 326719 326
Cras_giga Crassostrea gigas Pacific oyster 29159 520
Lott_giga Lottia gigantea Owl limpet 225164 495
Ilya_obso Ilyanassa obsoleta Eastern mudsnail 34582 250
Lymn_stagn Lymnaea stagnalis Pond Snail 6523 544
Eupr_scolo Euprymna scolopes Squid 6613 215
Stron_purp Strongylocentrotus purpuratus Sea Urchin 7668 538
Para_livi Paracentrotus lividus Purple Sea Urchin 7656 297
Sacc_kowa Saccoglossus kowalevskii Acorn Worm 10224 268
Cion_inte Ciona intestinalis Sea Squirt 7719 466
Cion_savi Ciona savignyi Sea Squirt 51511 458
Halo_rore Halocynthia roretzi Sea Squirt 7729 463
Bran_flor Branchiostoma floridae Amphioxus 7739 C3ZMY0 493
Petr_mari Petromyzon marinus Lamprey 7757 406
BACE1
Hum_BACE1 Homo sapiens Human 9606 P56817 501
Mouse_BACE1 Mus musculus Mouse 10090 P56818 501
Rat_BACE1 Rattus norvegicus Rat 10116 P56819 501
Dog_BACE1 Canis familiaris Dog 9615 501
Bov_BACE1 Bos taurus Cow 9913 Q2HJ40 501
Mono_dome_BACE1 Monodelphis domestica Opossum 13616 466
Ailu_melan_BACE1 Ailuropoda melanoleuca Panda 9646 501
Orin_anat_BACE1 Ornithorhynchus anatinus Platypus 9258 475
Gall_Gal_BACE1 Gallus gallus Chicken 9031 426
Taen_gutt_BACE1 Taeniopygia guttata Zebra Finch 59729 522
Xeno_trop_BACE1 Xenopus tropicalis Western clawed frog 8364 Q0P4T5 502
Anol_caro_BACE1 Anolis carolinensis Lizard 28377 318
Pelo_sine_BACE1 Pelodiscus sinensis Chinese Soft- Shelled Turtle 13735 484
Chry_pict_BACE1 Chrysemys picta bellii Western painted Turtle 8478 437
Dani_reri_BACE1 Danio rerio Zebrafish 7955 531
Taki_rubr_BACE1 Takifugu rubripes Fugu 31033 443
Tetr_nigr_BACE1 Tetraodon nigroviridis Pufferfish 99883 Q4RYS5 448
Gast_acul_BACE1 Gasterosteus aculeatus Sticklback 69293 490
Oryz_lati_BACE1 Oryzias latipes Medaka 8090 442
(Continued)
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Table 2 | Continued
Short sequence name Species name Common name NCBI Tax ID UniProt ID Protein length
Lat_chal_BACE1 Latimeria chalumnae Coelocanth 7897 488
Gadu_morh_BACE1 Gadus morhua Cod 8049 481
Oreo_nilo_BACE1 Oreochromis niloticus Nile Tilapia 8128 488
Salm_salm_BACE1 Salmo salar Atlantic Salmon 8030 348
Leuc_erin_BACE1 Leucoraja erinacea Little Skate 7782 203
Squa_acan_BACE1 Squalus acanthias Spiney Dogfish 7797 202
BACE2
Hum_BACE2 Homo sapiens Human 9606 Q9Y5Z0 518
Mouse_BACE2 Mus musculus Mouse 10090 Q9JL18 515
Rat_BACE2 Rattus norvegicus Rat 10116 Q6IE75 514
Dog_BACE2 Canis familiaris Dog 9615 422
Cow_BACE2 Bos taurus Cow 9913 473
Mono_dome_BACE2 Monodelphis domestica Opossum 13616 531
Orni_anat_BACE2 Ornithorhynchus anatinus Platypus 9258 423
Ailu_melan_BACE2 Ailuropoda melanoleuca Panda 9646 426
Xeno_laev_BACE2_A Xenopus laevis African Clawed Frog 8355 Q7T0Y2 500
Xeno_laev_BACE2_B Xenopus laevis African Clawed Frog 8355 Q6PB20 499
Xeno_trop_BACE2 Xenopus tropicalis Western Clawed Frog 8364 B4F734 499
Anol_carol_BACE2 Anolis carolinensis Lizard 28377 417
Amb_tigr_BACE2 Ambystoma tigrinum tigrinum Eastern tiger salamander 43116 337
Pelo_sine_BACE2 Pelodiscus sinensis Chinese Soft-Shelled Turtle 13735 415
Chry_pict_BACE2 Chrysemys picta bellii Western painted Turtle 8478 438
Gall_gall_BACE2 Gallus gallus Chicken 9031 416
Taen_gutt_BACE2 Taeniopygia guttata Zebra Finch 59729 441
Dani_reri_BACE2 Brachydanio rerio Zebrafish 7955 503
Taki_rubr_BACE2 Takifugu rubripes Fugu 31033 470
Tetr_nigr_BACE2 Tetraodon nigroviridis Spotted Green Pufferfish 99883 472
Oryz_lati_BACE2 Oryzias latipes Medaka 8090 437
Gast_acul_BACE2 Gasterosteus aculeatus Sticklback 69293 508
Gadu_morh_BACE2 Gadus morhua Cod 8049 497
Lati_chum_BACE2 Latimeria chalumnae Coelocanth 7897 382
Oreo_nilo_BACE2 Oreochromis niloticus Nile Tilapia 8128 509
Onco_myki_BACE2 Oncorhynchus mykiss (+nerka) Rainbow Trout 8022 406
Salm_sala_BACE2 Salmo salar Atlantic Salmon 8030 230
BASAL CATHEPSINS
Plan_schm_cath01 Schmidtea mediterranea Planarium 79327 389
Tric_adhe_cath01 Trichoplax adhaerens Tricoplax 10228 B3RK44 383
Bran_flor_cath01 Branchiostoma floridae Amphioxus 7739 C3YBT8 423
Mono_ovat_cath01 Monosiga ovata Choanoflagellate 81526 381
Nema_vect_cath01 Nematostella vectensis Sea Anemone 45351 370
Stro_purp_cat01 Strongylocentrotus purpuratus Sea Urchin 7668 313
Cion_inte_cath01 Ciona intestinalis Sea Squirt 7719 385
Cion_sauv_cath01 Ciona savignyi Sea Squirt 51511 H2ZA35 370
et al., 2009). The sequence in question (Q9VLK3) fails all the
criteria we described above and, on the basis of similarity, the
most plausible classification is a lysosomal cathepsin. This is
regardless of whether the enzyme may exibit the beta-secretase
activity of APP-clipping under certain experimental conditions,
as has been reported for other cathepsins (Schechter and Ziv,
2011).
The following database matches were recorded as borderline
but, because of low identity scores, truncations and absence of
corroborative data, they were not included in the multiple align-
ments. A partial sequence (GAA56694) from the Liver Fluke
Clonorchis sinensis gives reciprocal BACE1 scores but has no diag-
nostic matches in InteProScan and the primary data was not
retrievable from the genome portal. The marine metagenome
partial ORF EBK78785 also has BACE1 as top reciprocal match
and a C-terminal TM domain but it has only 27% identity with
extensive gapping and neighbor matches indicative of it being an
algal protein.
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IDENTIFICATION OF SEQUENCE FEATURES
Figure 1 shows a representative set of InterProScan outputs for
two Ur-BACEs, the human BACEs and a cathepsin.
The diagnostic utility of InterProScan results is not only for
family and subfamily memberships but also for judging sequences
to be full-length. As expected, the pepsin/cathepsin architecture
is confirmed by all the global alignment matches. Three of the
PRINTS local alignment patterns proved useful to distinguish
between BACE family (PRO815), BACE1 (PRO1816), and BACE2
(PRO1817) (Attwood et al., 2012). Notably, the specificity of
the matches extends to the Ur-BACEs, even though the profile
is historically compiled from mammalian sequences. Ur-BACEs
predominantly matched the BACE1 profile and none the BACE2
profile. For sequences with complete N-terminals, InterProScan
detected either a tmhmm (∼50%) or a SignalP (∼30%) hit,
and sometimes both. We interpret this as indicating a secretion-
associated signal peptide cleavage as a universal feature. Similarly,
all UrBACEs indicated the presence of a C-terminal transmem-
brane section. We provide a summary of matching across the
entire sequence set in Figure 2.
EXTENDED PHYLOGENY
A gene tree of the entire set of protein sequences from Table 2 is
shown in Figure 3A. The UrBACE sequences alone are shown in
Figure 3B. The alignment underlying this analysis is available as a
Nexus file at http://purl.org/phylo/treebase/phylows/study/TB2:
S14732 and both sets of sequences are supplied in FASTA format
in the Supplementary Data file.
Figure 3 shows four distinct clusters with the two vertebrate
BACEs generally well resolved from the Ur-BACEs and their
cathepsin homologs. While we have restricted the vertebrate
sequences to major groupings (more orthologs can be accessed
via Ensembl GeneTree if required) they recapitulate expected fea-
tures. For example, BACEs from the new Turtle genomes cluster
with birds, as concluded in the recent publication (Shaffer et al.,
2013). However, there are departures from a simple evolutionary
model based on duplication in the fish linage. In the vertebrate
clades, Xenopus tropicalis contains a clearly identifiable BACE1
and BACE2. However, the two homologs identified in X. lae-
vis both clustered with X. tropicalis BACE2, share 90% sequence
identity as paralogs, and are therefore designated as BACE2a and
BACE2b.
Branch lengths within the BACE2 family appear longer than
those for BACE1. To quantify this we compared equivalent
sequence distances between the protein sets. The two X. laevis
BACE2s were excluded from the analysis, as was the P. marinus
UrBACE although this clustered with the duplicated BACEs. The
average sequence difference for BACE1s was 0.317 whereas that
for BACE2s was 0.551. The mean BACE2/BACE1 ratio for all
comparisons was 2.36. Of 190 comparisons 150 showed greater
distances for BACE2 than BACE1 while 40 showed a greater dis-
tance for BACE1 than BACE2. This suggests that BACE2 protein
sequences have evolved more rapidly than BACE1. As this result is
based on protein sequences, it likely suggests that purifying selec-
tion has acted more strongly on BACE1 than BACE2. The full
distance matrix for the data set as generated by BIONJ is available
in the Supplementary Data file.
The UrBACE sequences lie outside the two well-supported
BACE clades with the exception of Petromyzon marinus UrBACE,
which clusters close to the BACE1 grouping. Notably, two
UrBACE sequences were identified for Monosiga ovata and three
for Trichoplax adhaerens. The latter can be localized as an ordered
cluster in the genome (Ensembl scaffold_4:758759-790622) but
since none are complete ORFs in the browser mark-up (although
our version of Tric_adhe_A was extended to 545 residues by ab
initio gene prediction) the exon pattern and possible duplication
history of the three is unclear. Both of these UrBACE paralogous
sets have long branch lengths (e.g., the Monosiga pair shares only
∼45% identity) suggesting that these duplications are ancient
events independent of the duplication event giving rise to the
BACE1 and BACE2 families. Amongst UrBACEs, most major
groupings are supported, although protostomes do not resolve
as a monophyletic group. An anomalous result is the high boot-
strap value separating the tunicates (Ciona and Halocynthia) not
only from other chordates but from all other UrBACEs. This may
suggest that these sequences derive from a different duplication
lineage to the other UrBACEs and the BACEs.
BLOCKS ANALYSIS
Figure 4 shows that despite the divergence of their sequences
conserved blocks are consistently spaced between the different
BACEs. Exceptions are the insert in Schistosoma mansoni and
deletion in Trichoplax adhaerens (Tric_adhe_B). The Sequence
Logo results are shown in Figure 5 and the mapping of these onto
a BACE1 PDB structure in Figure 6.
As expected, the catalytic sites correspond to two of these
blocks (blocks 1 and 4). Blocks 2 and 3 align with the ligand con-
tact shell, indicated by the red triangles, while the remaining two
blocks are associated with internal fold positions but also include
conserved cysteines involved in disulphide bonding. Inspection
of the ConSurf option in PDBSum indicates that essentially all 6
UrBACE blocks and the conserved (purple) residues in Figure 5
correspond to buried internal parts of the structure. Note that
this analysis provides different but complementary results to the
InterProScan and phylogeny results. The former show matches
to pre-existing sequences and recognize the terminal domain
features that typically do not crystallize. The blocks analysis
shows divergence among the UrBACEs despite the common fold
architecture. However, despite the nominal presence of catalytic
residues, the extensive insertions in the Schistosoma japonicum
sequence (if confirmed via cDNA data) suggest it could be catalyt-
ically non-functional, which could explain the anomalous branch
length in the phylogenetic tree.
Many experiments have indicated the crucial role played by
the BACE1 C-terminal, including S-palmitoylation at four Cys
residues at the junction of the transmembrane and cytosolic
domains. Although this has no discernible influence on BACE1
processing of APP in mouse, it traffics BACE1 dimers into
cholesterol-rich lipid rafts (Vetrivel et al., 2009). While the ques-
tion of the occupancy stoichiometry of the lipid chains between
the Cys positions remains, there are no reports that BACE2 has
the equivalent post-translational modification (PTM). For the
UrBACE sequences block generation breaks down in this part of
the multiple alignment although it did indicate all four Cys to be
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FIGURE 1 | InterProScan Sequence Features. Representative examples
are shown for two Ur-BACEs (A) Monosiga ovata A (Mono_ovat_A), (B)
Strongylocentrotus purpuratus (Stron_purp), (C) human BACE1
(Hum_BACE1) (D) human BACE2 (Hum_BACE2), and (E) a cathepsin
from Monosiga ovata (Mono_ovat_cath01). The protein length is
indicated.
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FIGURE 2 | Summary of InterProScan pattern hits for the proteins included in Table 2.
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FIGURE 3 | Protein trees of BACE protein sequences. Sequences are
labeled as in Table 2. Black dots indicate sequences with accession
numbers for complete ORFs in Table 2. Solid vertical bars represent
bootstrap values of 100% and open bars represent bootstrap values
of 95% or greater but less than 100%. Sequences corresponding to
high order taxa are enclosed in colored boxes as indicated by the
legends in the figures. (A): All sequences analyzed; (B): Ur-BACE
sequences only.
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FIGURE 4 | Blocks generated from the UrBACE sequences. The six
conserved regions are shown in N-terminal to C-terminal order.
absolutely conserved in BACE1. While this suggests the palmitoy-
lation could be pan-vertebrate, it raises the evolutionary question
as to whether this is also a constitutive feature in BACE2 and/or
the UrBACE. We explored the variation in the C-termini by using
T-Coffee (Figure 7).
The results corroborate the very high conservation for the
BACE1 C-terminal residues including the palmitoylated Cys can-
didates. It also indicates a possible single Cys candidate for BACE2
(at around 563 in the alignment) but this is absent in Xenopus
and the gapping reflects low conservation. The difference for
the UrBACEs is striking in that conservation falls off rapidly in
the C-terminal cytoplasmic tail directly distal to the TM domain
boundary. It can be noted here that the Strongylocentrotus pur-
puratus insert is confirmed by many ESTs (i.e., is not a gene
prediction artifact). Significantly, a quartet of Cys candidates can
be discerned, with the fourth one around position 615, despite
the gapping in this region.
Notably, within the UrBACEs the block-type conservation co-
exists with variation in conservation patterns and length at the
termini. We interpret the blocks as being directly associated (as
part of the active site) or indirectly (as the core buried 3D fold sec-
tions) associated with catalysis. In contrast the signatures of the
signal peptide and the CTM are physical property-based. They are
thus not only less conserved as sequences per se but also less con-
strained in position (even though the CTM needs to be a defined
membrane-spanning length) as they are surface features. This also
explains why UrBACEs vary by up to 100 residues in length.
Ka/Ks ANALYSIS
The ratio of non-synonymous (protein sequence-changing) to
synonymous (non-protein sequence-changing) mutation rates
within a sequence, referred to as the Ka/Ks ratio, is an indicator
of the strength of purifying selection. A low ratio indicates strong
purifying selection; a value close to 1 indicates no selection, and a
value above 1 positive selection (adaptive change of the sequence).
Analysis was carried out on complete cDNA sequences and indi-
vidual exons to reveal any differential selection along the length
of the gene. The sets that could be analyzed (i.e., cDNAs of equal
length) had to be different between BACE1 and BACE2, because
of the limited availability of complete mammalian sequences.
For BACE1, sequences from H. sapiens, A. melanoleuca, S. scrofa.
E. caballus, O. cuniculus, B. taurus, M. musculus, and R. norver-
gicus were analyzed. For BACE2, these were from H. sapiens,
B. taurus, S. scrofa, M. musculus, R. norvegicus, and P. capensis.
The values presented in Table 3 are the overall mean values
for the sequence set generated by SLAC (Kosakovsky Pond and
Frost, 2005). For the whole genes, Ka/Ks ratios were well below
1, indicating a predominant role for purifying selection in the
evolution of mammalian BACE genes. Values for BACE2 were
generally higher (i.e., less stringent selection) than for BACE1.
This is consistent with more rapid evolution of BACE2 seen in the
phylogenetic analysis, although the datasets here are not directly
comparable due to their different compositions. Analysis of indi-
vidual exons showed weaker purifying selection acting on the 5′
(N-terminal) end of the gene, especially exon 1, while the cen-
tral region of the gene showed low values (strongest selection)
although the patterns differed between BACE1 and BACE2. Exon
8 of BACE2 in particular showed an elevated Ka/Ks value.
The signal and pro-peptide domains showed elevated Ka/Ks.
In BACE2, but not in BACE1, high Ka/Ks was also observed for
the C-terminal transmembrane domain. None of these Ka/Ks val-
ues approached 1, suggesting weaker purifying selection rather
than positive selection when Ka/Ks ratio were higher. This is not
unexpected, given that these surface-exposed sections are con-
strained more by the more general physical residue properties
for membrane interaction than sequence conservation per se. The
fact that we noted lower Ka/Ks in the BACE1 C-terminal may be
related to the importance of the lipid anchoring features referred
to above.
It should be noted that the Ka/Ks analysis is restricted to mam-
mals as opposed to the deeper taxonomic levels dealt with via
the larger protein sequence comparisons described in the previ-
ous section. However, the evolutionary insights they provide are
complementary.
PHYLOGENETIC DISTRIBUTION OF SUBSTRATES
We tested for the presence of a small number of reportedly
significant BACE1 and BACE2 human substrates in model organ-
isms and selected phylum representatives. We included presenilin
1 (PSEN1) as a highly conserved component of the gamma
secretase complex as a comparison. The BLAST results (see
Supplementary Data file) are summarized in Figure 8.
The figure indicates discordant evolutionary trajectories
between the BACEs and the human substrates. Given the long
divergence times, where BLAST scores were low (e-5–e-8) it was
difficult to discriminate between short domain matches (e.g., the
disulphide-rich Kunitz domain in APP) and extended but low
similarity scores indicating possible orthology. However, identity
and match length were useful guides. We thus conclude that APP
is absent from Trichoplax and Ciona, NRG1 and SCN2B are only
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FIGURE 5 | Sequence Logos for the six conserved UrBACE blocks in N-terminal to C-terminal order (with spacing shown in Table 2). Residue letter
height is an index of conservation.
Frontiers in Genetics | Bioinformatics and Computational Biology December 2013 | Volume 4 | Article 293 | 12
Southan and Hancock BACE1 and BACE2 evolution
FIGURE 6 | The blocks from Figure 3 and Logos from Figure 4, aligned
against a BACE1 PDBSum entry. Among the many entries with different
ligands the longest sequence was chosen, 3lpi. The 2D display is shaded red
to purple for conserved residues but note these are derived from BACE1
alignments (i.e., do not include UrBACEs). The secondary structure elements
in dark blue and other marked features are described in the PDBSum
features. The red arrows, added from this work, correspond to the six
UrBACE sequence blocks.
present in Zebrafish but TMEM27 is present only in Zebrafish
and Ciona. In Drosophila and C. elegans we see the opposite case
of APP homologs in the absence of BACE-like sequences.
GENE EXPRESSION
The consensus from many investigations is that BACE1 is pre-
dominantly a neuronal protein in humans, although glia cells may
also produce significant amounts. However, systematic expres-
sion data is still sparse outside humans and mouse. We mined
high-level expression patterns for BACEs using the Bgee resource
(Bastian et al., 2008). While this collates expression data for
human, mouse, zebrafish, Xenopus and Drosophila, coverage is
patchy and difficult to standardize between ESTs and microarray
probes. Expression patterns for BACE1 and BACE2 in human,
mouse and Xenopus are compared in Table 4. Broadly, BACEs 1
and 2 showed similar expression patterns with a few exceptions.
In human the only notable difference between them was that
BACE2 was reported to be expressed in pancreas whereas BACE1
was not. In mouse, BACE2 was additionally expressed in the skin
and prostate gland while BACE1 was not, and in the endocrine
system BACE2 was restricted to the pineal gland whereas BACE1
was also expressed in the adrenal gland and neurohypophysis. In
Xenopus, although both BACE1 and BACE2 were expressed in the
testis they otherwise had distinct expression patterns: BACE1 was
expressed in the brain while BACE2 was expressed in the oviduct,
skin and spleen. No expression data were available for Zebrafish.
DISCUSSION
In this paper we havemined existing complete and partial genome
sequences for new BACE gene families. Blending a range of
resources by manual annotation produced a rich dataset, much
of it not readily available from sequence databases. This allowed
us to shed new light both on the evolutionary history of the BACE
genes and on putative shifts in protein function and substrate
interactions. We can consequently suggest future functional char-
acterizationmaking use of a range ofmodel organisms that will be
relevant to development of new therapies for Alzheimer’s Disease
and Type 2 Diabetes Mellitus.
EVOLUTIONARY TRAJECTORIES
Our sampling of most major phyla clearly delineates an
“UrBACE.” What we mean by this is the ancestral BACE-like
sequence lineage with properties distinct from cathepsin-like pre-
cursors. The similarity scores and domain arrangement indicate
that the emergence of this lineage was a distinct rather than
gradual event and possibly related to the shuffling-in of a CTM
domain into the 3′ exon. This would significantly change cellu-
lar trafficking and pH optima. We cannot detect any apparent
intermediate form, such as a cathepsin with a CTM domain. By
implication, these UrBACE sequences underwent selection for
altered or new biochemical functions after duplication. This may
have taken place before the origin of the choanoflagellates in the
late Precambrian at least 860 MYA (million years ago) (Hedges
et al., 2006; Blair, 2009).
Our results show that the Ur-BACE has a rich and previously
undocumented history of gene duplication with preservation in
different lineages. The most prominent is that leading to BACE1
and BACE2 after the divergence of the Hyperoartia (represented
here by P. marinus) from the Gnathostomata (see Figure 3).
This divergence, dated at c 530 MYA (Hedges et al., 2006; Blair,
2009), corresponds to the so-called 3R whole genome duplica-
tion (Holland et al., 1994; Miyata and Suga, 2001; Venkatesh
et al., 2007; Hufton et al., 2008). This might have given rise to the
paralogous and persistent BACE1 and BACE2 lineages, although
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FIGURE 7 | T-Coffee alignments of C-termini for (A) BACE1, (B) BACE2, and (C) UrBACE. The inputs were restricted to complete termini but also needed
the removal of the Monosiga and Trichoplax sequences to give an informative result for panel (C).
phylogenetic analysis of other gene families suggests that different
scenarios are possible (Kuraku et al., 2009).
Our phylogeny deviates from current taxonomic groupings
but it should be noted that it has the known constitutive limi-
tations of a gene-specific analysis. In particular, we would have
expected the Cnidaria to be more basal. However, much of this
deviation reflects the poor resolution of this part of the phy-
logeny, which contains few groups supported by high (>95%)
bootstrap values. Despite this, the main taxonomic groups are
mostly monophyletic except for the Protostomia. The clustering
of the three CionaUrBACEs away from the chordate lineage when
we would have expected them to lie closest to B. floridae is also
notable.
Gene duplication, whether or not it is associated with whole
genome duplication, is a well-known process allowing the explo-
ration of functional space by a gene family. It is thought that
most duplicates are lost due to purifying selection or neutral
drift soon after emergence, as they accumulate inactivating muta-
tions (Lynch and Conery, 2000; Lynch and Force, 2000; Lynch
et al., 2001). Long-term persistence of gene duplicates, as we have
recorded here, is therefore prima facie evidence of both func-
tional importance and differentiation in a gene family. This can
be reflected in subfunctionalization (the redistribution of the
ancestral gene’s functions between its daughter genes) or neo-
functionalization (the evolution of a new function by one of the
duplicates) (Lynch and Force, 2000; Lynch et al., 2001).
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Table 3 | Results of Ka/Ks analysis for subsections of BACE1 and
BACE2 cDNA sequences.
Sequence BACE1 BACE2
AA Coords Ka/Ks AA Coords Ka/Ks
(Human protein) (Human protein)
All 1–501 0.040 1–518 0.144
DOMAINS
Signal 1–21 0.284 1–20 0.156
Propeptide 22–45 0.127 21–62 0.282
Chain 46–501 0.025 63–518 0.126
Extracellular 46–457 0.025 63–473 0.124
Transmembrane 458–478 0.000 474–494 0.303
Intracellular 479–501 0.053 495–518 0.093
EXONS
Exon 1 1–87 0.139 1–104 0.216
Exon 2 88–117 0.000 105–134 0.105
Exon 3 118–189 0.014 135–206 0.060
Exon 4 190–235 0.032 207–249 0.057
Exon 5 236–280 0.007 250–294 0.040
Exon 6 281–314 0.000 295–328 0.059
Exon 7 315–364 0.000 329–378 0.027
Exon 8 365–422 0.008 379–435 0.211
Exon 9 423–501 0.028 436–518 0.140
Just coding sequences were used (i.e., excluding untranslated regions). Values
marked in bold exceed the overall value for the complete cDNAs.
FIGURE 8 | Presence/absence of BACE1 and BACE substrates on six
selected proteome sets from completed genomes. Boxes to the right
represent likely orthology matches to the human sequences for BACE1
(P56817), APP (P05067), NRG1 (Q02297), SCN2B (O60939), TMEM27
(Q9HBJ8), and PSEN1 (P49768). An X represents their probable absence by
low BLASTP score.
It has been suggested that duplicated genes undergo accel-
erated evolution immediately after duplication as they adapt to
new functions and undergo a concomitant increase in Ka/Ks
(Lynch and Conery, 2000). Our analyses of branch lengths in
the BACE1 and BACE2 families supports such an asymmetry in
evolutionary rates leading to accelerated functional diversifica-
tion of BACE2 with implied preservation of ancestral function
in BACE1. Estimates of Ka/Ks based on complete cDNAs from
Table 4 | Expression of BACE1 and BACE2 in human, mouse, and
Xenopus.
Anatomical
locus
BACE1 BACE2
Human Mouse Xenopus Human Mouse Xenopus
Cardiovascular
system
Y Y Y Y
Respiratory
system
Y Y Y Y
Haematological
system
Y Y
Lymphoreticular
system
Y Y Spleen
Alimentary
system
Y Y Y Y
Urogenital
system
Y Y Testis Y Y Testis
Oviduct
Endocrine
system
Y Y Y Pineal
gland
only
Musculoskeletal
system
Y Y Y Y
Dermal system Y Y Y Y
Nervous
system
Y Y Brain Y Y
Pancreas N Y
Sensory organ
system
Y Y
Prostate Y
Presence of expression is marked by Y unless a more specific locus is
mentioned. N, No expression is reported in contrast to BACE2.
a subset of mammalian species indicated higher values in BACE2
but no evidence of positive selection. This suggests relaxed puri-
fying selection has acted on BACE2, which is consistent with
functional diversification. Purifying selection on these proteins
has nevertheless remained strong, implying important biological
functions.
An anomaly in the scenario above is that the X. laevis whole
genome duplication (produced by allotetraploidization circa 50
MYA) may have led to eventual loss of both BACE1s. This con-
founds the otherwise pan-vertebrate post-duplication persistence
of the two paralogs. However, there is a caveat in that polyploid
genomes are particularly difficult to assemble, so the “missing”
BACE1(s) may yet be discovered in X. laevis. Notwithstanding, if
their absence is confirmed, we make the following experimentally
testable predictions. The first is an expression split in X. lae-
vis if one of the BACE2s has shifted into the BACE1 neuronal
role. There is a precedent for this from a study showing differ-
ential expression of 14% of X. laevis paralogous pairs, indicative
of polyploidy-related subfunctionalization (Morin et al., 2006).
We consider the alternative scenario of substitution of the BACE1
roles by another protease to be less likely, since this would
need a radical functional shift to occur in X. laevis over a rel-
atively short evolutionary timescale, but this is also a testable
prediction.
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Two loss-of-function fates can befall post-duplication enzyme
copies. The first is decay to a non-translated pseudogene; the sec-
ond is abrogation of catalytic function, typically due to mutations
in the vicinity of the active site (i.e., the sequence is selectively
maintained but for some non-proteolytic function). While nei-
ther of these can be ruled out for all individual species represented
here (or their existence at a significant allelic frequency in cer-
tain populations) we suggest that, as a general case, neither of
these processes has played a significant role in the evolutionary
trajectory of the UrBACEs or the resulting persistence of the
BACE paralogs in the vertebrates. Observations supporting this
conjecture can be summarized as follows:
1. None of the 78 sequences showed frame shifts or premature
stop codons characteristic of pseudogenes.
2. EST sampling or TSA virtual cDNA assembly serves as a
useful proxy for protein expression (although pseudogenes
can show low levels of transcription). While transcript cov-
erage is patchy in UrBACE-containing phyla, in cases where
EST numbers were high, we usually detected extensive ORF
coverage. This was found to be full length for Acropora mille-
pora, Strongylocentrotus purpuratus, and Ciona intestinalis.
Even for less sampled species such as Schmidtea mediter-
ranea we found ESTs covering the 5′ and 3′ of the cDNA
(DN315134 and DN303898).
3. For vertebrates, 24 Unigene entries (i.e., clustered ESTs and
mRNAs) for BACE1 and 26 for BACE2 can be found. This
verifies gene transcription in a significant number of species.
4. In regard to the active site residues (equivalent to Asp93
and Asp289 in human BACE1) the proximal Asp was iden-
tifiable in 67 of 78 sequences and the distal Asp289 in 72
of 78 (regardless of whether the neighboring residues con-
formed to Prosite PS00141 or not). Cases where one of these
was missing could be attributable to genomic assembly or
gene prediction errors. Thus, pending cDNA verification
for predicted ORFs, our data set contains no evidence of
non-catalytic UrBACEs or BACEs.
There is a possible exception in the form of an extensive insertion
in the Schistosoma japonicum gene sequence (Figure 4) which, if
confirmed, suggests, despite the presence of two active site Asps, a
severe disruption of folding. Consequent catalytic inactivity could
also explain the anomalous branch length in the phylogenetic tree
and could be associated with evolutionary drift into new func-
tions for this parasite. We cannot rule out, and indeed might
expect that additional ancient duplications in the UrBACE lineage
could have resulted in pseudogenization of some copies (the alter-
native being complete deletion). However, completely finished
genomes would be needed to detect such cryptic duplications.
SUBSTRATE PATTERNS
Our analysis of substrate co-occurrence is more of a preliminary
assessment than a comprehensive analysis. It had to be limited,
not only because the set of reported BACE substrates is contin-
ually expanding but also because of the scale of the analysis that
would be needed to discern the evolutionary trajectory for all of
them. Nevertheless, we show clear cases of phylogenetic discor-
dance from mammalian protease/substrate pairings that could
possibly have co-evolved. For example, Drosophila has an APP
homolog but no Ur-BACE, while Ciona has an Ur-BACE but no
APP homolog. We thus show that this type of investigation may
provide an indication of significant role shifts occurring between
species over long divergence times. The automated GeneTree fea-
ture in Ensembl can also be used to follow the evolution of any
selected substrate (with the caveat that coverage of basal phyla is
more limited than we explore here).
PUTATIVE Ur-BACE FUNCTIONS
The minimum evolutionary model for the BACE gene family is
that the UrBACE emerged at the base of the metazoan tree via the
duplication of a cathepsin and the shuffling-in of the C-terminal
TM domain. This is particularly significant because it thereby
joins the limited number of proteases participating in regulated
intramembrane proteolysis (RIP) of which APP beta-secretase is
the archetype (Lal and Caplan, 2011; Lichtenthaler et al., 2011).
Whether the Placozoans are basal to the Choanoflagellates in phy-
logenetic terms as urmetazoans, or vice versa, is still a subject for
debate (Osigus et al., 2013). However, we detected further dupli-
cation, divergence and maintenance of the resulting paralogs in
these smallest known urmetazoan gene repertoires [e.g.,Monosiga
brevicollis and Trichoplax adherens have only 9200 and 11,500 pro-
teins, respectively (King et al., 2008; Srivastava et al., 2008)]. This
argues for functional importance, as does their persistence for
the subsequent ∼800 million years. The absence of human-BACE
substrates in organisms with one or more Ur-BACE sequences
suggests these ancestral enzymes have different substrates and
roles to those in humans. However, their loss in Ecdysozoans
implies they can be functionally substituted by other proteases.
Considerations of possible ancestral functions based on bioin-
formatic evidence alone are speculative. Nevertheless, by extrap-
olating from mammalian BACE1 (which has greater similarity to
Ur-BACE sequences than BACE2) we can suggest the Ur-BACEs
might also have a neuronal role. While this would fit with our
detection of the enzyme at the base of Bilateria (with primitive
nervous systems) and the Cnidaria (with nerve nets), the counter
argument would be that Placozoans and Choanoflagellates have
no synaptically connected neurons. However, the surprise from
the draft genomes of members of these phyla was that they not
only showed extensive human protein homology but also sim-
ilar domain combinations. The recent report that these phyla
both express sodium channels included the suggestion that
the evolution of these predates the origin of nervous systems
(Liebeskind et al., 2011; Zakon, 2012). An independent observa-
tion echoes this in detecting a primordial neurosecretory appara-
tus in a choanoflagellate, identified via a SNARE protein complex
(Burkhardt et al., 2011). Notably, A. queenslandica neither con-
tains Na(v)-like channels nor an UrBACE while BACE1 regulates
Na(v)1 channels in mouse neuronal cells by sequential process-
ing of the SCN2B regulatory subunit (Kovacs et al., 2010). The
question thus arises as to whether the UrBACE co-evolved for
ion channel processing as one of its earliest functions after it
acquired the CTM and RIP potential but this will also have to
await experimental testing. These lines of evidence suggest that
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some of the molecular repertoire for multi-cellularity and signal-
ing preceded the appearance of the nervous system and were later
co-opted for their evolution.
The presumed functional divergence after duplication of
BACEs points toward BACE1 maintaining the primary function
of the UrBACE, or at least overlapping more closely with it than
BACE2. However, intriguing implications arise from the recently
reported functions of BACE2. One of these is the observation
that pancreatic β-cells have many characteristics in common with
nerve cells and may thus share with them a common evolutionary
origin via gut cells co-opting a neuronal transcriptional program
(Arntfield and van der Kooy, 2011). For example, while Hagfish
and Lampreys have a pancreas made up almost entirely of β-cells,
in Amphioxus these cells are associated with the intestinal tis-
sue in a dispersed form (Pieler and Chen, 2006). An additional
implication of an ancestral neuronal connection for BACE2 is
that melanophore pigmentation cells are developmentally derived
from the neural crest (Quigley et al., 2004). We can thus postu-
late that BACE2 was co-opted initially in a neuronal context (e.g.,
via the post-duplication gene dosage advantage) but later became
selected for functions no longer confined to neural cells per se (i.e.,
neofunctionalization).
FUTURE WORK
Experimental characterization of ancestral BACE sequences,
aided by the results presented, here, should have two impor-
tant and related facets. The first is the purely scientific focus
on biochemical and physiological roles for these enzymes in the
complex degradomic protease webs that can now be compared
between different phyla (auf dem Keller et al., 2007). Together
with further bioinformatics analysis of basal eumetazoans, such
work will reveal hitherto unknown roles, including the process-
ing of new substrates that could have important implications for
human BACE1 and BACE2. In addition, standardized compar-
ative expression patterns across a wider variety of species will
provide insight into pre- and post-gene duplication tissue speci-
ficity within and between taxa. Characterization of UrBACE(s)
and putative homologous substrates may give more interpretable
phenotypic and omics-profiling signatures compared to organ-
isms with more complex gene repertoires. Some species with
UrBACE sequences already have established experimental func-
tional genomics platforms. For example, Ciona is used for study-
ing chordate central nervous system regeneration (Dahlberg et al.,
2009). These investigations will not only provide new testable
hypotheses but also analogous putative substrate studies in C. ele-
gans andDrosophila (UrBACE-negative organisms) could provide
informative controls.
The second facet of further research relates to the crucial sta-
tus of these enzymes as drug targets. This pair is unusual in being
catalytically similar but the very different therapeutic indications
in different tissues have been validated about a decade apart.
Given the huge and increasing scale of unmet medical need for
both AD and T2DM, progression toward clinical candidates for
either target is to be earnestly hoped for. However, such first-
in-class inhibitors face significant hurdles. Those directed against
BACE1 will need (1) high dosing to cross the blood-brain bar-
rier, (2) probably require life-long treatment, and (3) will need
to be administered early to patients who are asymptomatic but
with a robustly predictive biomarker profile (Karran et al., 2011).
Under such circumstances, any new aspects of BACE biochem-
istry, implied or directly revealed by functional genomics, are
going to be important. This would not only be in a predictive
context for efficacy, toxicology and side effects, but also because
new substrates can provide candidate biomarkers for clinical eval-
uation. While studies in mice and Zebrafish could be deemed
potentially most informative, there is no phylogenetic grouping
where experimental results could be considered irrelevant.
While BACE2 inhibition for T2DM has a longer way to go
before clinical proof-of-concept, a review of recent patent pub-
lications indicates pharmaceutical company discovery programs
for this indication have been running since 2010 (Southan, 2013).
The major factors that might accelerate development are (1)
the large collection of BACE1 inhibitor structures in PDB, (2)
the collective experience in their optimization that can provide
starting points for BACE2 inhibitors, and (3) unlike for BACE1,
compounds need not be brain penetrant. Two years ago the num-
bers of compounds with inhibition results published in patents
and papers was 5459 and 414 for human BACE1 and BACE2
respectively [supplementary data from (Southan et al., 2011)].
The BACE2 results were entirely from cross-screening of BACE1-
directed inhibitors. The equivalent inhibitor structure ratio from
published papers in ChEMBL (release 16, June 2013) is now 3815
to 527, suggesting increased interest in BACE2.
The potential importance of new insights revealed by func-
tional genomics applies equally for both enzymes, especially since
the double-target status poses important new specificity ques-
tions. In the hitherto absence of predictable in vivo consequences
of BACE2 inhibition, the specificity ratio (i.e., the BACE1:BACE2,
IC50, or Ki) for a BACE1 lead compound was probably set empir-
ically at ∼100-fold. Development projects will now need to be
more circumspect on how they choose this ratio; including mon-
itoring for effects on the turnover of BACE2 substrates and β-cell
function, as well as reciprocally monitoring BACE2 inhibitors for
effects on the turnover of BACE1 substrates.
Our results have additional utility for chemical biology where
these pure and applied facets intersect. For example, BACE
inhibitors specific for either or both paralogs could be used as sys-
tem probes in the way that inhibitors have already been used for
mouse and fish experiments. This is analogous to genomic loss-
of-function but with the inherent advantages of small-molecule
perturbation (e.g., rapid onset, precise dosing, mixture testing,
analog testing, developmental stage specificity and reversal by
wash-out). These can be informative when compared with activ-
ity ablation by RNAi, mutation or knockout. Such chemical
perturbations could be tried out in basal phyla where we have
identified Ur-BACEs with local active-site sequence similarities of
50% or above. Results are likely to be relevant to both the AD and
T2DMdrug discovery efforts. They could also lead to new types of
BACE inhibitor cross-screens utilizing the moderate throughput
phenotypic read-outs that these basal organisms can offer.
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